Dehydro Aripiprazole | Certified Solution Standard | Abilify

Dehydro aripiprazole,	D-053
1.0 mg/mL in Methanol with 5% 1N HCl Dehydro Aripiprazole is the primary, active metabolite of aripiprazole, marketed as the atypical antipsychotic Abilify for the treatment of schizophrenia, bipolar disorder, and clinical depression. This new certified solution standard is suitable for use in LC or GC applications including forensic or clinical toxicology analysis and urine drug testing.

In addition to Aripiprazole (A-080) and its stable labeled internal standard Aripiprazole-D₈ (A-081), we offer certified solution standards of other atypical antipsychotics and their metabolites and internal standards, such as quetiapine, risperidone, clozapine, ziprasidone, and olanzapine.

Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO 17034 and ISO/IEC 17025 & certified ISO 9001.

All New Product Announcements